Axel Mark: Ascella Biosystems Inc. wins research grant to develop infectious disease diagnostic technology
Axel Mark: Notice regarding partial changes to the Articles of Incorporation
Axel Mark: Notice regarding job offers for executive personnel
Axel Mark: Announcements of individual stock for the establishment of a subsidiary.
AXEL MARK: Ad distribution platforms “AXEL MARK DSP” and “AdRoute” in the post-cookie era strengthen distribution of retargeting advertisements
AXEL MARK: Notice Concerning the Recording of Non-Operating Profit
AXEL MARK: (Cancellation of disclosure matters) Notice of cancellation of basic agreements relating to stock transfer agreements involving changes in subsidiaries, etc.
Axel Mark: Notice Concerning the Recording of Non-Operating Profit
Axel Mark: Obtaining a Class 2 medical device manufacturing and sales license to promote the healthcare business
Axel Mark: Launch of “AXEL MARK DSP,” an advertisement distribution platform for the post-cookie era
Axel Mark: Notice of conclusion of a basic agreement on share transfer agreements involving changes in subsidiaries, etc.
Axel Mark: Plans for complying with listing maintenance standards
Axel Mark: Explanatory materials on business plans and growth potential
Axel Mark: (Progress of disclosure matters) Notice regarding full-scale entry into the healthcare business
Axel Mark: Independent Officer Notification Form
Axel Mark: Notice regarding job offers for executive personnel
Axel Mark: Notice regarding a business alliance with HM.Y. Co., Ltd. and the start of a new business (trading card business)
Axel Mark: Notice Concerning the Selection of Directors with Roles
Axel Mark: Explanatory materials on business plans and growth potential
Axel Mark: Articles of association 2022-12-23
No Data
No Data